News Releases
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
- Jan 22, 2019
FARMINGDALE, N.Y., Jan. 22, 2019 (GLOBE NEWSWIRE) -- Misonix, Inc. (NASDAQ: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices that...
- Jan 18, 2019— Proven Pharmaceutical Leader Brings Deep, Global Experience with Successful Product Launches, Commercialization and Strategic Planning —
BRISBANE, Calif.--(BUSINESS WIRE)--Jan. 18, 2019-- Aimmune Therapeutics, Inc. (Nasdaq: AIMT), a biopharmaceutical company developing treatments for potentially life-threatening food allergies,...
- Jan 15, 2019
MIAMI, Jan. 15, 2019 (GLOBE NEWSWIRE) — Veru Inc. (NASDAQ: VERU), an oncology and urology biopharmaceutical company, today announced that four abstracts have been accepted for poster...
- Jan 14, 2019Company Plans to Submit NDA in 2019
MIAMI, Jan. 14, 2019 (GLOBE NEWSWIRE) — Veru Inc. (NASDAQ: VERU), an oncology and urology biopharmaceutical company, today announced that the clinical trial of the Company’s proprietary...
- Jan 11, 2019
TORONTO--(BUSINESS WIRE)-- Acerus Pharmaceuticals Corporation (TSX: ASP) (“Acerus” or the “Company”) is today advising that it has reported an anticipated shortage of certain doses of...
- Jan 04, 2019
BRISBANE, Calif.--(BUSINESS WIRE)--Jan. 4, 2019-- Aimmune Therapeutics, Inc. (Nasdaq: AIMT), a biopharmaceutical company developing treatments for potentially life-threatening food allergies,...
- Jan 04, 2019--Patients tolerated as much as 2,000 mg of peanut protein with fewer adverse events --
LISBON, Portugal--(BUSINESS WIRE)--Jun. 4, 2019-- Aimmune Therapeutics, Inc. (Nasdaq: AIMT), a biopharmaceutical company developing treatments for life-threatening food allergies, today announced...
- Jan 04, 2019
Keystone Dental Inc. ("Keystone"), the largest independent dental implant company operating in North America, has entered into a definitive agreement to merge via a stock exchange transaction with...
- Jan 03, 2019The Los Angeles Chargers Girls will also be visiting to help bring awareness to this community-driven initiative
BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, and TeamSmile, the nation's premier advocacy group that supports life-changing dental care for underserved children and the...
- Jan 02, 2019
BRISBANE, Calif.--(BUSINESS WIRE)--Jan. 2, 2019-- Aimmune Therapeutics, Inc. (Nasdaq: AIMT), a biopharmaceutical company developing treatments for life-threatening food allergies, today announced...